By Erika Wu, Business Development Manager, Global Tech Hubs, LSN
Life Science Nation (LSN) proudly announces that California Life Sciences (CLS) will serve as a title sponsor for RESI JPM again. RESI JPM is LSN’s flagship conference taking place January 9-11, 2024, at Marines’ Memorial Club & Hotel, San Francisco, during JP Morgan Healthcare week.
Earlier this year, during RESI JPM 2023, CLS not only brought many their members to participate in RESI but also featured 8 early-stage life science startups across the biotech and medtech sectors in the RESI Innovator’s Pitch Challenge (IPC) as part of the CLS Innovation Track. This section successfully connected these outstanding life science innovators with LSN’s global investors and partners.
Read: Interview with Shikha Sharma, Senior Director, Innovation at California Life Sciences (CLS)
RESI JPM 2024 will see over 500 investors and licensing partners and 500 fundraising executives congregate during JPM week, CLS will bring their members who are early-stage life science startups to participate in RESI JPM which will serve to further the visibility and growth of these fundraising firms with LSN’s global partner network. With this excellent event for collaboration, CLS will bring into the spotlight many of the elite technology assets emerging from the state’s most impactful life sciences trade association. As part of CLS’s portfolio of entrepreneurship services, CLS seeks to establish partnerships with respected partnering and investor conferences to aid CLS members in their fundraising journeys. Importantly, opportunities like RESI connect them with Seed and Series B investors, channels, and licensing partners.
CLS is the state’s most impactful life sciences membership organization, advocating for the sector and its diverse innovation pipeline. For more than 30 years, CLS has served the community by supporting companies of all sizes, from early-stage innovators and startups to established industry leaders in the fields of biotechnology, pharmaceuticals, and medical technology. As integral components of a healthy and collaborative ecosystem, CLS also works closely with universities, academic and research institutions, the investment community, and other critical partners that promote this vibrant sector. On behalf of our more than 1,200 member organizations, CLS works to shape public policy, improve access to breakthrough technologies, educate lawmakers, and advance equity within our ecosystem by championing innovative solutions for some of the most pressing challenges of our times. In doing so, CLS fulfills its mission to protect and nurture California’s life sciences industry, empowering discoveries that lead to healthier lives around the world.
Next Phase Newsletter 
Leave a comment